Found 3 hits for monomerid = 50390073 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Sodium channel protein type 9 subunit alpha
(Homo sapiens (Human)) | BDBM50390073
(CHEMBL2069400)Show SMILES CN1CCN(CC1)c1cccc2OC[C@H](Cc12)NC(=O)c1ccc(OC(F)(F)F)cc1 |r| Show InChI InChI=1S/C22H24F3N3O3/c1-27-9-11-28(12-10-27)19-3-2-4-20-18(19)13-16(14-30-20)26-21(29)15-5-7-17(8-6-15)31-22(23,24)25/h2-8,16H,9-14H2,1H3,(H,26,29)/t16-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human NaV1.7 expressed in HEK293 cells by whole-cell voltage clamp assay |
Bioorg Med Chem Lett 22: 5618-24 (2012)
Article DOI: 10.1016/j.bmcl.2012.06.105 BindingDB Entry DOI: 10.7270/Q2ZC83ZX |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50390073
(CHEMBL2069400)Show SMILES CN1CCN(CC1)c1cccc2OC[C@H](Cc12)NC(=O)c1ccc(OC(F)(F)F)cc1 |r| Show InChI InChI=1S/C22H24F3N3O3/c1-27-9-11-28(12-10-27)19-3-2-4-20-18(19)13-16(14-30-20)26-21(29)15-5-7-17(8-6-15)31-22(23,24)25/h2-8,16H,9-14H2,1H3,(H,26,29)/t16-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 7.94E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by IonWorks HT assay |
Bioorg Med Chem Lett 22: 5618-24 (2012)
Article DOI: 10.1016/j.bmcl.2012.06.105 BindingDB Entry DOI: 10.7270/Q2ZC83ZX |
More data for this Ligand-Target Pair | |
Sodium channel protein type 5 subunit alpha
(Homo sapiens (Human)) | BDBM50390073
(CHEMBL2069400)Show SMILES CN1CCN(CC1)c1cccc2OC[C@H](Cc12)NC(=O)c1ccc(OC(F)(F)F)cc1 |r| Show InChI InChI=1S/C22H24F3N3O3/c1-27-9-11-28(12-10-27)19-3-2-4-20-18(19)13-16(14-30-20)26-21(29)15-5-7-17(8-6-15)31-22(23,24)25/h2-8,16H,9-14H2,1H3,(H,26,29)/t16-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay |
Bioorg Med Chem Lett 22: 5618-24 (2012)
Article DOI: 10.1016/j.bmcl.2012.06.105 BindingDB Entry DOI: 10.7270/Q2ZC83ZX |
More data for this Ligand-Target Pair | |